title: Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient.
authors.affiliation: III Division of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Sollima
authors.affiliation: III Division of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Milazzo
authors.affiliation: III Division of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Torre
authors.affiliation: III Division of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
authors.forename: Elisa
authors.initials: E
authors.lastname: Calvi
authors.affiliation: Liver Unit, Department of Surgery, National Cancer Institute, IRCCS Foundation, Naples, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Regalia
authors.affiliation: III Division of Infectious Diseases, L. Sacco University Hospital, Milan, Italy.
authors.forename: Spinello
authors.initials: S
authors.lastname: Antinori
mesh_terms: D015081:2-Naphthylamine; D000813:Anilides / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use*; D060085:Coinfection; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005838:Genotype; D006085:Graft Survival; D015658:HIV Infections / Q000150:complications*; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000150:complications / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D047029:Lactams, Macrocyclic; D016031:Liver Transplantation / Q000009:adverse effects*; D047028:Macrocyclic Compounds / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011392:Proline / Q000031:analogs & derivatives; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome; D014498:Uracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014633:Valine
chemical_list: D000813:Anilides; D000998:Antiviral Agents; D002219:Carbamates; D003521:Cyclopropanes; D007166:Immunosuppressive Agents; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds; D012367:RNA, Viral; D013449:Sulfonamides; C586094:ombitasvir; D014498:Uracil; D011392:Proline; D015081:2-Naphthylamine; C588260:dasabuvir; D014633:Valine; D019438:Ritonavir; C585405:paritaprevir